PATHOLOGIC PROCESSES
Clinical trials for PATHOLOGIC PROCESSES explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC PROCESSES trials appear
Sign up with your email to follow new studies for PATHOLOGIC PROCESSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart monitor may cut AFib recurrence after ablation
Disease control OngoingThis study tests whether using an insertable heart monitor to guide early treatment can reduce the amount of time people spend in atrial fibrillation (AFib) after a catheter ablation procedure. About 120 adults with AFib will receive the monitor and be followed for 15 months. The…
Matched conditions: PATHOLOGIC PROCESSES
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
Could a cancer drug cut surgeries for rare throat condition?
Disease control OngoingThis study tests if bevacizumab, a drug that blocks blood vessel growth, can help adults with recurrent respiratory papillomatosis (RRP) go longer between surgeries. RRP causes wart-like growths in the airways that often return after removal. About 21 participants will receive th…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Could ifetroban ease scleroderma lung damage?
Disease control OngoingThis study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…
Matched conditions: PATHOLOGIC PROCESSES
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:55 UTC